Published in
Springer, Cellular Oncology, 4(42), p. 491-504, 2019
DOI: 10.1007/s13402-019-00448-w
Links
Tools
The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cells
Journal article published in 2019 by
Majid Momeny 
,
Fatemeh Esmaeili,
Sepideh Hamzehlou,
Hassan Yousefi,
Sepehr Javadikooshesh,
Vasimeh Vahdatirad,
Zivar Alishahi,
Seyedeh H. Mousavipak,
Davood Bashash ,
Ahmad R. Dehpour,
Seyyed M. Tavangar,
Javad Tavakkoly-Bazzaz,
Peiman Haddad,
Farzaneh Kordbacheh,
Kamran Alimoghaddam
and other authors.
,
Fatemeh Esmaeili,
Sepideh Hamzehlou,
Hassan Yousefi,
Sepehr Javadikooshesh,
Vasimeh Vahdatirad,
Zivar Alishahi,
Seyedeh H. Mousavipak,
Davood Bashash ,
Ahmad R. Dehpour,
Seyyed M. Tavangar,
Javad Tavakkoly-Bazzaz,
Peiman Haddad,
Farzaneh Kordbacheh,
Kamran Alimoghaddam
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 